ENZYCHEM LIFESCIENCES CORPORATION
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
183490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7183490002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 제천시 바이오밸리로 59, 제천시
- Website:
- https://www.enzychem.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Enzychem Lifesciences Corporation is a clinical-stage biopharmaceutical company developing novel small molecule therapeutics for inflammatory diseases, oncology, and severe respiratory conditions. The company's primary focus is its lead candidate, EC-18 (Mosedipimod), an oral immunomodulator designed to target fundamental inflammation pathways. Its development pipeline addresses significant unmet medical needs, including chemoradiation-induced oral mucositis (CRIOM), chemotherapy-induced neutropenia (CIN), and acute radiation syndrome (ARS). In addition to its research and development in new drugs, the company also develops and manufactures Active Pharmaceutical Ingredients (APIs).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-20 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 33.2 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.9 MB | ||
| 2025-06-10 00:00 |
Transaction in Own Shares
신탁계약해지결과보고서
|
Korean | 21.5 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.7 MB | ||
| 2025-04-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 93.4 KB | ||
| 2025-04-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 95.3 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 26.9 KB | ||
| 2025-03-24 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 95.3 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.3 KB | ||
| 2025-03-18 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 2.5 MB | ||
| 2025-03-12 00:00 |
Major Shareholding Notification
신탁계약에의한취득상황보고서
|
Korean | 49.5 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 264.6 KB | ||
| 2025-03-07 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 216.5 KB | ||
| 2025-03-06 00:00 |
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 18.8 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 15.3 KB |
Automate Your Workflow. Get a real-time feed of all ENZYCHEM LIFESCIENCES CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ENZYCHEM LIFESCIENCES CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ENZYCHEM LIFESCIENCES CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
